Talking Strategic Development with Simtra at DCAT

Published on: 


Ray Guidotti, Chief Operating Officer at Simtra BioPharma Solutions, talks about the company's strategic development and how it supports customers with a focus on excellence.

Simtra BioPharma Solutions is a premier contract development and manufacturing organization (CDMO) with more than 65 years of sterile injectable (SI) experience and a dedicated focus on providing a range of services from clinical development to commercial fill/finish. Learn more about:

  • Simtra’s new building in Halle that features a high-speed syringe line and vial line equipped with four lyophilizers and is expected to be GMP ready in 2024.
  • The new clinical line in Bloomington that will be ready to take on projects in the summer of 2025.
  • Construction of the new state-of-the-art building in Bloomington that will begin in the summer of 2024.